文献速递产科母胎医学

母胎医学会特别声明:对产后再入院率作为质量指标的批判

Society for Maternal-Fetal Medicine Special Statement: A critique of postpartum readmission rate as a quality metric.
PubMed 文献 · Am J Obstet Gynecol · 2021-11-25

该声明指出,产后再入院率虽易追踪,但缺乏标准化指标、基线率仅1%~2%难以区分随机变异与可控因素、需风险调整、随访时长影响偏倚、存在博弈可能、缺乏证据表明产科提供者能影响该率,且可能对脆弱产后人群造成意外伤害,因此目前作为质量或绩效改进指标及调整报销因素的效用有限。

要点

  • 产后再入院率基线仅1%~2%,过低难以区分随机变异与可控因素。
  • 缺乏标准化指标、需风险调整、随访时长影响偏倚且存在博弈可能。
  • 无证据表明产科提供者能影响再入院率,且可能对脆弱产后人群造成意外伤害。

核心结论

  • 在相关问题得到充分解决前,产后再入院率目前作为质量或绩效改进指标及调整提供者报销因素的效用有限。

研究设计与样本

  • 母胎医学会特别声明,基于对产后再入院率作为质量指标的批判性分析。

主要发现

  • 产后再入院率基线为1%~2%,过低难以准确区分随机变异与可控因素。
  • 缺乏标准化指标,需风险调整使率计算复杂化。
  • 随访间隔时长可导致偏倚,存在对指标进行博弈的可能。
  • 缺乏证据表明产科提供者能影响再入院率,且可能对脆弱产后人群造成意外伤害。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hospital readmission is considered a core measure of quality in healthcare. Readmission soon after hospital discharge can result from suboptimal care during the index hospitalization or from inadequate systems for postdischarge care. For many conditions, readmission is associated with a high rate of serious morbidity and potentially avoidable costs. In obstetrics, for postpartum care specifically, hospitals and payers can easily track the rate of maternal readmission after childbirth and may seek to incentivize obstetricians, maternal-fetal medicine specialists, or provider groups to reduce the rate of readmission. However, this practice has not been shown to improve outcomes or reduce harm. There are major concerns with incentivizing providers to reduce postpartum readmissions, including the lack of a standardized metric, a baseline rate of 1% to 2% that is too low to accurately discriminate between random variation and controllable factors, the need for risk adjustment that greatly complicates rate calculations, the potential for bias depending on the duration of the follow-up interval, the potential for the "gaming" of the metric, the lack of evidence that obstetrical providers can influence the rate, and the potential for unintended harm in the vulnerable postpartum population. Until these problems are adequately addressed, maternal readmission rate after a childbirth hospitalization currently has limited utility as a metric for quality or performance improvement or as a factor to adjust provider reimbursement.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Combs CA, Goffman D, Pettker CM, et al. Society for Maternal-Fetal Medicine Special Statement: A critique of postpartum readmission rate as a quality metric. Am J Obstet Gynecol. 2021. PMID: 34838802. doi:10.1016/j.ajog.2021.11.1355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。